Radiopharmaceuticals for Skeletal Muscle PET Imaging

被引:2
|
作者
Park, Joo Yeon [1 ]
Park, Sun Mi [1 ]
Lee, Tae Sup [2 ]
Kang, Seo Young [1 ]
Kim, Ji-Young [1 ]
Yoon, Hai-Jeon [1 ]
Kim, Bom Sahn [1 ]
Moon, Byung Seok [1 ]
机构
[1] Ewha Womans Univ, Coll Med, Dept Nucl Med, Seoul 07804, South Korea
[2] Korea Inst Radiol & Med Sci, Div RI Applicat, Seoul 01812, South Korea
基金
新加坡国家研究基金会;
关键词
positron emission tomography; radiopharmaceutical; skeletal muscle atrophy; GLUCOSE-UPTAKE; BLOOD-FLOW; MANAGEMENT; MECHANISMS;
D O I
10.3390/ijms25094860
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The skeletal muscles account for approximately 40% of the body weight and are crucial in movement, nutrient absorption, and energy metabolism. Muscle loss and decline in function cause a decrease in the quality of life of patients and the elderly, leading to complications that require early diagnosis. Positron emission tomography/computed tomography (PET/CT) offers non-invasive, high-resolution visualization of tissues. It has emerged as a promising alternative to invasive diagnostic methods and is attracting attention as a tool for assessing muscle function and imaging muscle diseases. Effective imaging of muscle function and pathology relies on appropriate radiopharmaceuticals that target key aspects of muscle metabolism, such as glucose uptake, adenosine triphosphate (ATP) production, and the oxidation of fat and carbohydrates. In this review, we describe how [18F]fluoro-2-deoxy-D-glucose ([18F]FDG), [18F]fluorocholine ([18F]FCH), [11C]acetate, and [15O]water ([15O]H2O) are suitable radiopharmaceuticals for diagnostic imaging of skeletal muscles.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
    Jothilingam Sivapackiam
    Monica Sharma
    Thomas H. Schindler
    Vijay Sharma
    Current Cardiology Reports, 2020, 22
  • [22] Imaging of Skeletal Muscle
    Goodwin, Douglas W.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2011, 37 (02) : 245 - +
  • [23] PET and PET/CT imaging of skeletal metastases
    Cook, Gary J. R.
    CANCER IMAGING, 2010, 10 (01) : 153 - 160
  • [24] Ultrahigh Resolution Coplanar PET Imaging of Microfluidic Devices for Synthesizing PET Radiopharmaceuticals
    Groll, Andrew
    Kim, Kyungsang
    Li, Quanzheng
    Meng, Ling-Jian
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [25] PET Radiopharmaceuticals
    Shahhosseini, Soraya
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (01): : 1 - 2
  • [26] Noninvasive PET Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering
    Haralampieva, Deana
    Betzel, Thomas
    Dinulovic, Ivana
    Salemi, Souzan
    Stoelting, Meline
    Kramer, Stefanie D.
    Schibli, Roger
    Sulser, Tullio
    Handschin, Christoph
    Eberli, Daniel
    Ametamey, Simon M.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (09) : 1467 - 1473
  • [27] New PET radiopharmaceuticals beyond FDG for brain tumor imaging
    Gulyas, B.
    Halldin, C.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (02): : 173 - 190
  • [28] Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications
    Franquet, Elisa
    Park, Hyesun
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2022, 9
  • [29] PET/CT Imaging of Infectious Diseases: Overview of Novel Radiopharmaceuticals
    Calabria, Ferdinando F.
    Guadagnino, Giuliana
    Cimini, Andrea
    Leporace, Mario
    DIAGNOSTICS, 2024, 14 (10)
  • [30] Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging
    Tiwari, Ashok
    Andriotty, Matthew
    Agasthya, Greeshma
    Sunderland, John J.
    Osborne, Dustin R.
    Kapadia, Anuj J.
    MEDICAL PHYSICS, 2025, 52 (02) : 801 - 813